Skip to main content

Trupanion, Inc.

corporate_fare Company Profile

Trupanion, Inc.

TRUP·NASDAQ·Finance·CIK 0001371285

Trupanion provides medical insurance for cats and dogs in the United States, Canada, and certain countries in Continental Europe. The company offers high-value medical insurance products, priced based on each pet's unique characteristics and coverage level. Trupanion operates in two reporting segments: subscription business and other business. The subscription business segment generates revenue primarily through insurance premiums, referred to as subscription payments, from direct-to-consumer products. Within this segment, Trupanion also offers "Powered by Trupanion" pet insurance products marketed by third parties, low and medium average revenue per pet products under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland. The company either directly underwrites or assumes full insurance risk for these products through reinsurance arrangements. Additionally, in certain countries in Continental Europe, the company offers products underwritten by third parties who pay commissions recognized as revenue. The other business segment generates revenue from other product offerings, primarily by underwriting policies on behalf of third parties with whom the company generally has a business-to-business relationship. This segment has a significantly lower margin profile than the subscription business segment.

Trupanion, Inc. (NASDAQ:TRUP) is a publicly traded company in the Finance sector. Wiseek has independently scored 8 items for TRUP at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for TRUP spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Trupanion Q3: Revenue Up 11% to $405.6M, Net Income $9.3M, $25M Buyback Executed
  • Trupanion Q3 Revenue Up 11% to $405.6M, Net Income $9.3M; $25M Buyback Executed
  • Trupanion Tops Q2 Revenue, Authorizes $100M Buyback
  • Trupanion Q2 Revenue Beats, $100M Buyback and $44M Dividend Authorized
  • Pet Insurer Trupanion Hits $4 Billion in Claims, Accelerating Growth to 3.9M Pets

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.44B
Diluted EPS
$0.45
Op. Cash Flow
$89.49M
Free Cash Flow
$75.36M
Gross Profit
$231.01M
Operating Income
$13.84M
Cash & Equivalents
$138.02M
Total Debt
$111.78M
Debt / Equity
0.29×
Net Margin
0.0%
Shares Outstanding
43.4M sh
Source: 10-K · filed 2026-02-13 · accession 0001371285-26-000018

Short Interest & Short Volume

11.22 days to cover

FINRA reported short interest of 3,926,253 shares in TRUP as of the October 30, 2026 settlement, a 6.8% increase from the prior period — about 11.2 days to cover at its recent average daily volume. On November 20, 2026, 33.0% of TRUP volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,926,253 shares as of October 30, 2026
Change vs prior period▲ 6.8%
Days to cover11.22 at avg daily volume of 349,864
Daily short volume (FINRA facilities)33.0% of 151,108 shares on November 20, 2026
5-day average short volume50.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for TRUP, detected from its recent SEC filings.

1 shelf registration

Aflac Resale Shelf Renewed · No Proceeds to Trupanion

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with T →
$35.56
52-week range · as of 2026-11-05 $21.16 – $46.98
Market cap
$1.54B
Volume
495.4K (1.1× avg)
3-mo avg 434.2K
Live data · 2026-11-22 01:19 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TRUP - Latest Insights

TRUP
Nov 05, 2026, 5:13 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $29.00
Real-time Price: $35.56 info
Change: +$6.56 (+23%) info
Market Cap: $1.539B info
TRUP
Nov 05, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.72
Real-time Price: $35.56 info
Change: +$0.840 (+2%) info
Market Cap: $1.539B info
TRUP
Aug 05, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $25.10
Real-time Price: $35.56 info
Change: +$10.46 (+42%) info
Market Cap: $1.539B info
TRUP
Aug 05, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $25.10
Real-time Price: $35.56 info
Change: +$10.46 (+42%) info
Market Cap: $1.539B info
TRUP
May 26, 2026, 11:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.79
Real-time Price: $35.56 info
Change: +$13.77 (+63%) info
Market Cap: $1.539B info
TRUP
Apr 30, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $24.00
Real-time Price: $35.56 info
Change: +$11.56 (+48%) info
Market Cap: $1.539B info
TRUP
Feb 13, 2026, 4:07 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $27.96
Real-time Price: $35.56 info
Change: +$7.60 (+27%) info
Market Cap: $1.539B info
TRUP
Feb 12, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $32.29
Real-time Price: $35.56 info
Change: +$3.27 (+10%) info
Market Cap: $1.539B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets